004: Finding Funding In Volatile Times With Dr. Ben Zeskind
Business Of Biotech
00:00
The Key Indicators of a Successful Exit Strategy
The company had a nice partial exit along the way in 2015, where we sold part of our company to a large large pharma company. I think it's really those two factor: The general psychology of the markets and how that particular company is doing. Then, you know, exits are driven a lot by the specifics of the technology and the relationship. You know, last week when the markets were plunging over the coronavirus fears, I don't think that was a time when anyone was really thinking of buying, buying other companies or anything like that.
Play episode from 26:34
Transcript
